Conferences

We invite you to submit your abstract and participate in the upcoming 6th International Symposium on Frontiers in Molecular Science (ISFMS 2027), taking place from 14–17 September 2027 in Barcelona, Spain.

We cordially invite you to attend this event organized by MDPI International Journal of Molecular Sciences (ISSN: 1422-0067, IF: 5.6). This in-person conference brings together leading experts, researchers and R&D teams to share their insights across trends in biochemistry and molecular biology.

Event Chairs
Prof. Dr. José L. Quiles (University of Granada, Spain)
Prof. Dr. Antonio Pisani (University of Pavia, Italy)

Abstract Submissions are Open!
Don’t miss this opportunity to directly connect and showcase your work to peers and leading experts.

Submit your abstracts by 14 May 2027 using the following link:
https://sciforum.net/user/submission/create/1810

Find out more about the instructions for authors:
https://sciforum.net/event/ISFMS2027?section=#instructions

Find out more about the publication opportunities available for authors:
https://sciforum.net/event/ISFMS2027?section=#PublicationOpportunities

Please feel free to share information about this conference to your colleagues and students. We look forward to hearing your research in Barcelona!

The ISFMS 2027 Organizing Committee,
6th International Symposium on Frontiers in Molecular Science (ISFMS 2027)
isfms@mdpi.com

https://sciforum.net/event/ISFMS2027

We cordially invite you to attend the following event organized by the MDPI journal Molecules (ISSN 1420-3049, Impact Factor: 4.6). The conference will take place online from 27 to 29 September 2027.

Conference Name:

The 1st International Online Conference on Molecules (IOCMO 2027)

Conference Chair:

Prof. Dr. Thomas J. Schmidt, Molecules Editor-in-Chief, Institute of Pharmaceutical Biology and Phytochemistry, University of Münster, Münster, Germany

Topics of interest:

S1. Organic Synthesis and Medicinal Chemistry;
S2. Natural Products Chemistry and Food Chemistry;
S3. Bioorganic Chemistry and Chemical Biology;
S4. Inorganic, Coordination, Photo- and Electrochemistry;
S5. Materials, Macromolecular and Nanochemistry;
S6. Analytical Chemistry and Molecular Sensing;
S7. Physical, Computational and Theoretical Chemistry;
S8. Applied and Green Chemistry, Sustainable Technologies.

Important dates:

Deadline for abstract submission: 28 May 2027;
Notification of acceptance: 29 June 2027;
Deadline for registration: 21 September 2027.

Best Oral Presentation Award and Best Poster Award:

• For the Best Oral Presentation Award, the winners will receive a certificate and CHF 150 each;
• For the Best Poster Award, the winners will receive a certificate and CHF 50 each.

Guide for authors:

To submit your abstract, please click the following link: https://sciforum.net/user/submission/create/1822.

To register for the event, please click the following link: https://sciforum.net/event/IOCMO2027?section=#registration.

For details regarding Abstract Submission, Poster and Slide Submission, and Publication Opportunities, please refer to the “Instructions for Authors” section on the following website: https://sciforum.net/event/IOCMO2027?section=#instructions.

For any enquiries regarding this event, please contact us at iocmo2027@mdpi.com.

We look forward to seeing you at IOCMO 2027.

https://sciforum.net/event/IOCMO2027

Dear Researchers,

We are pleased to announce that the 2nd International Electronic Conference on Medicinal Chemistry and Pharmaceutics (ECMC-P 2026) will be held on https://sciforum.net/event/ECMC-P2026 from 1 to 30 November 2026. This conference is organized by the MDPI open access journals Pharmaceuticals (ISSN 1424-8247; IF: 4.8) and Pharmaceutics (ISSN 1999-4923; IF: 5.5) and will be chaired by Prof. Dr. Maria Emília Sousa, Prof. Mary J. Meegan, Dr. Alfredo Berzal-Herranz, Prof. Dr. Thierry Vandamme and Prof. Dr. Francisco Javier Otero Espinar. Participation in this conference is free of charge.

The conference will be organized around the aims and scope of the journal Pharmaceuticals and Pharmaceutics, which includes the following general topics:

S1. Invited Lectures;
S2. General;
S3. New Small Molecules as Drug Candidates;
S4. Natural Products and Biopharmaceuticals;
S5. Novel Methodologies and AI;
S6. New Modalities in Drug Discovery;
S7. Radiopharmaceuticals;
S8. Nanomedicine and Nanotechnology;
S9. Formulation, Drug Delivery, and Controlled Release;
S10. Biopharmaceutics, Disposition, Pharmacokinetics and Pharmacodynamics.

During the conference, you will be able to comment on other presentations and otherwise engage with fellow scholars in real time. In this way, the conference offers a novel opportunity to exchange opinions and views within the scholarly community and to discuss papers and the latest research in a discussion forum.

This platform seeks to provide a discussion forum for scientists around the world to share recent developments and innovative ideas in medicinal chemistry and pharmaceutics. This will allow students, researchers, and experts to share their latest theories, results, models, and applications within this multidisciplinary area of knowledge.

Important Dates
Abstract Submission Deadline: 10 September 2026
Acceptance Notification Deadline: 30 September 2026
Full Description Submission Deadline: 2 October 2026
Registration Deadline: 30 October 2026

Guide for Authors
To submit your abstract, please click the following link:
https://sciforum.net/user/submission/create/1844
To register for the event, please click the following link:
https://sciforum.net/event/ECMC-P2026?section=#registration

For more information about the procedure for submission, peer review, revision, and acceptance, please refer to the section “Instructions for Authors”.

Awards
The open access, peer-reviewed journals Pharmaceuticals and Pharmaceutics will present awards totaling CHF 1600 for the Best Poster, Best Slideshow, Best Flash Communication, and Best Communication. Additionally, one participant will be granted the opportunity to engage in a One-Day Microwave Practice/Test. All submissions will be evaluated independently of their respective sessions. Members of the Scientific Committee will be responsible for selecting the winning entries based on predefined criteria.

For any enquiries regarding the event, please contact ecmc-p@mdpi.com.

We look forward to receiving your research papers and to welcoming you to the 2nd International Electronic Conference on Medicinal Chemistry and Pharmaceutics!

Kind regards,
Conference Chairs

Prof. Dr. Maria Emília Sousa
Interdisciplinary Centre of Marine and Environmental Research (CIIMAR) and University of Porto, Porto, Portugal
Prof. Mary J. Meegan
School of Pharmacy and Pharmaceutical Sciences, Trinity Biomedical Sciences Institute, Trinity College Dublin, Ireland
Dr. Alfredo Berzal-Herranz
Instituto de Parasitología y Biomedicina López-Neyra, (IPBLN-CSIC), Spain
Prof. Dr. Thierry Vandamme
Laboratory for the Conception and Application of Bioactive Molecules, Faculty of Pharmacy, University of Strasbourg, France
Prof. Dr. Francisco Javier Otero Espinar
Department of Pharmacy and Pharmaceutical Technology, University of Santiago de Compostela, Spain

Your ECMC-P 2026 Organizing Team
ecmc-p@mdpi.com

https://sciforum.net/event/ECMC-P2026

We are pleased to announce that The 2nd International Conference on Bioengineering (BIOENG 2026) is back and it will take place from 10 to 13 November 2026 in Barcelona, Spain.

This conference is organized by MDPI’s open access journal Bioengineering (ISSN: 2306-5354, Impact Factor 4.4). Following the success of IOCBE 2024, an earlier edition in this series, BIOENG 2026 aims to gather leading minds from around the world once more to discuss transformative advances in bioengineering at the intersection with AI.

Conference Chairman
Prof. Dr. Anthony Guiseppi-Elie, Texas A&M University, USA

Session Topics of Interest
S1. Regenerative Engineering
S2. Biochemical Engineering
S3. Biosignal Processing
S4. Biomedical Engineering and Biomaterials
S5. Biomechanics and Sports Medicine
S6. Cellular and Molecular Bioengineering

Important Dates
Deadline for abstract submission: 31 July 2026
Abstract notification of acceptance: 3 September 2026
Deadline for Early Bird Registration: 10 September 2026
Deadline for Covering Author Registration: 10 September 2026
Deadline for Registration: 4 November 2026

Guide for Authors
To submit your abstract, please click on the following link: https://sciforum.net/user/submission/create/1424

To register for the event, please visit the following website: https://sciforum.net/event/BIOENG2026?section=#registration

For details regarding abstract submission, poster and slide submission, and publication opportunities, please refer to the “Instructions for Authors” section: https://sciforum.net/event/BIOENG2026?section=#instructions

We welcome you to partake in this opportunity to contribute to and shape the AI-enabled evolution of bioengineering.

For any enquiries regarding this event, please contact bioeng2026@mdpi.com.

https://sciforum.net/event/BIOENG2026

We are excited to announce that abstract submissions are now open for the 2nd International Conference on Pharmaceuticals and New Trends in Drug Discovery (ICOPharm-2), which will take place from 11 to 14 May 2027 in Lisbon, Portugal. This second edition of the conference is organized by MDPI’s journal Pharmaceuticals (ISSN 1424-8247; IF: 5.7).

Following the success of the inaugural conference, ICOPharm-2 will once again bring together leading researchers, scientists, and professionals from academia and industry to discuss the latest developments, challenges, and opportunities in pharmaceutical sciences and drug discovery. The conference will foster scientific exchange and collaboration across disciplines, highlighting innovative approaches and emerging trends that are shaping the future of pharmaceutical research and therapeutic development.

Topics of Interest

S1. Synthetic Chemistry and Drug Discovery
S2. Natural Products and Biopharmaceuticals
S3. Target Identification and Modes of Action
S4. Antimicrobial Agents and Strategies to Counter Resistance
S5. Novel Neurotherapies, Inflammation, and Pain Treatment
S6. Innovative Oncology Therapeutics and Precision Medicine

Important Dates

Abstract Submission Deadline: 15 January 2027
Early Bird Registration Deadline: 26 February 2027

Guide for Authors

To submit your abstract, please click on the following link: https://sciforum.net/submissions/ICOPharm2027/1

To register for the event, please click on the following link: https://sciforum.net/registration/ICOPharm2027/tickets

We are pleased to announce two prestigious awards that will be presented to outstanding contributors at ICOPharm-2: Best Oral Presentation Award and Best Poster Award.

We encourage all attendees to regularly visit the conference website for updates and detailed information regarding the awards and scientific program.

We look forward to your contribution to ICOPharm-2 and to welcoming you to Lisbon to participate in inspiring and engaging scientific exchange.

Kind regards,

Event Chairs
Prof. Dr. Amelia Pilar Rauter, University of Lisbon, Portugal
Prof. Dr. Mary Jane Meegan, Trinity College Dublin, Ireland
Dr. Jean Jacques Vanden Eynde, University of Mons-UMONS, Belgium
Your ICOPharm-2 Organizing Team
icopharm@mdpi.com

https://sciforum.net/event/ICOPharm2027

The 42nd Annual Meeting of the Japanese Society of Drug Delivery System (DDS42) is proud to announce its upcoming conference, bringing together researchers, clinicians, engineers, and industry professionals dedicated to advancing innovation in drug delivery science. This meeting reflects society’s continued commitment to fostering interdisciplinary collaboration and promoting cutting-edge discussions that drive the future of Drug Delivery Systems (DDS).

Under the theme “Aiming for the Pinnacle of DDS,” the conference draws inspiration from the summit of Mount Tsurugi, a sacred peak located in western Tokushima Prefecture. Just as Japan’s mountain ranges contain many unique peaks, the field of DDS encompasses diverse research areas and scientific approaches. By gathering experts from medicine, engineering, pharmacy, materials science, and related disciplines, DDS42 symbolizes a collective effort to reach new scientific heights and advance toward an even greater summit of innovation.

The theme also highlights the vital role of emerging scientists, emphasizing support for young researchers who are beginning their ascent toward future breakthroughs in DDS research. Set in the vibrant summer season of Tokushima, the meeting aims to create an energetic environment for knowledge exchange, collaboration, and passionate scientific dialogue.

Program highlights:

• Plenary and Special Lectures: Inspiring presentations from leading experts shaping the future of DDS research;
• Scientific Sessions: Multidisciplinary discussions covering fundamental science, translational research, and emerging technologies in drug delivery;
• Young Investigator Programs: Oral presentations, poster sessions, mentoring opportunities, and platforms supporting the next generation of scientists;
• Industry and Technology Exchange: Opportunities to explore innovations connecting academic research with clinical and industrial applications;
• Networking and Community Engagement: Social events and informal gatherings designed to strengthen collaborations across disciplines.

Key details:

• Date: 30–31 July 2026;
• Location: Awagin Hall (Tokushima Prefectural Local Culture Center), Tokushima, Japan;
• Audience: researchers, clinicians, pharmacists, engineers, industry professionals, students, and stakeholders involved in drug delivery science and technology.

We look forward to welcoming participants to Tokushima for DDS42 and engaging together in dynamic discussions that aim for the pinnacle of Drug Delivery Systems research.

For more information, please visit the official conference website:

https://dds42.mons.work/